Natural IgM-mediated innate autoimmunity: a new target for early intervention of ischemia-reperfusion injury (Q36960513)

17 August 2017

1 reference

title

Natural IgM-mediated innate autoimmunity: a new target for early intervention of ischemia-reperfusion injury (English)

1 reference

17 August 2017

Ming Zhang

1

1 reference

17 August 2017

Michael C Carroll

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

Expert Opinion on Biological Therapy

17 August 2017

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

10

1 reference

17 August 2017

page(s)

1575-1582

1 reference

Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Ischemic preconditioning attenuates ischemia-reperfusion-induced mucosal apoptosis by inhibiting the mitochondria-dependent pathway in rat small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

New concepts in reactive oxygen species and cardiovascular reperfusion physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Reactive species mechanisms of cellular hypoxia-reoxygenation injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Bench to bedside: the role of mitochondrial medicine in the pathogenesis and treatment of cellular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

The first minutes of reperfusion: a window of opportunity for cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Protein kinase activation and myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Role of protein kinase C in intestinal ischemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Inhibition of p38 mitogen-activated protein kinase may decrease intestinal epithelial cell apoptosis and improve intestinal epithelial barrier function after ischemia- reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Mechanisms of Gastrointestinal Ischemia‐Reperfusion Injury and Potential Therapeutic Interventions: A Review and Its Implications in the Horse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Effects of NF-kappa B inhibition on mesenteric ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Poly(ADP-ribose) polymerase activation in the reperfused myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Role of apoptosis in reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Oxidative stress-elicited myocardial apoptosis during reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Activation of immediate early gene, c-fos, and c-jun in the rat small intestine after ischemia/reperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

iNOS enhances rat intestinal apoptosis after ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Involvement of neutrophils in ischemia-reperfusion injury in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

P-selectin knockout mice have improved outcomes with both warm ischemia and small bowel transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

The inflammatory response in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Glucocorticoid-induced TNF receptor family gene (GITR) knockout mice exhibit a resistance to splanchnic artery occlusion (SAO) shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

A monoclonal antibody against cytokine-induced neutrophil chemoattractant attenuates injury in the small intestine in a model of ruptured abdominal aortic aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

CD11b Blockade Prevents Lung Injury despite Neutrophil Priming after Gut Ischemia/Reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

The role of the complement system in ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

C1-esterase inhibitor in ischemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Pexelizumab: a novel therapy for myocardial ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Complement amplification revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Human C1 esterase inhibitor attenuates murine mesenteric ischemia/reperfusion induced local organ injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Antiinflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Identification of the target self-antigens in reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Natural antibody mediated innate autoimmune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

NXY-059 for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Effects of edaravone on reperfusion injury in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Initiation of complement activation following oxidative stress. In vitro and in vivo observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Complement activation in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Complement activation after oxidative stress: role of the lectin complement pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Solution structure of Compstatin, a potent complement inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Role for complement in mediating intestinal nitric oxide synthase-2 and superoxide dismutase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Proteolytic activities of two types of mannose-binding lectin-associated serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Complement 1 inhibitor is a regulator of the alternative complement pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Improved right ventricular function after intracoronary administration of a C1 esterase inhibitor in a right heart transplantation model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Attenuation of skeletal muscle reperfusion injury with intravenous 12 amino acid peptides that bind to pathogenic IgM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Innate response to self-antigen significantly exacerbates burn wound depth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Usefulness of the serum complement component C4 as a predictor of stroke in patients with known or suspected coronary artery disease referred for coronary angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

Mice Deficient in Complement Receptors 1 and 2 Lack a Tissue Injury-Inducing Subset of the Natural Antibody Repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1575

10.1517/14712598.7.10.1575

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference